Emedastine
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 1-(2-ethoxyethyl)-2- (4-methyl-1,4-diazepan-1-yl)- benzoimidazole | |
| Clinical data | |
| Trade names | Emadine |
| AHFS/Drugs.com | monograph |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 87233-61-2 |
| ATC code | S01GX06 |
| PubChem | CID 3219 |
| DrugBank | APRD00946 |
| ChemSpider | 3106  |
| UNII | 9J1H7Y9OJV |
| KEGG | D07890 |
| ChEBI | CHEBI:4779 |
| ChEMBL | CHEMBL594 |
| Chemical data | |
| Formula | C17H26N4O |
| Mol. mass | 302.415 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Emedastine difumarate (Emadine) is an second generation antihistamine used in eye drops to treat allergic conjunctivitis. It's mechanism of action is a H1 receptor antagonist.
[edit] References
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
